152 related articles for article (PubMed ID: 7928246)
1. Experimental approach to the intra-arterial magnetic resonance imaging contrast media (Gd-DTPA-iodized oil) and new lipophilic gadolinium complex combined with iodized oil.
Yoshikawa K; Shiono T; Yamashita T; Iwai H; Abe O; Hisamatsu K; Takenaka E
Invest Radiol; 1994 Jun; 29 Suppl 2():S245-6. PubMed ID: 7928246
[No Abstract] [Full Text] [Related]
2. Neurotoxicity of contrast media for magnetic resonance imaging after generalized breakdown of the blood-brain barrier.
Evill CA; Wilson AJ; Fletcher MC; Sage MR
Acad Radiol; 1996 Aug; 3 Suppl 2():S336-8. PubMed ID: 8796597
[No Abstract] [Full Text] [Related]
3. New magnetic resonance imaging contrast agents for infarct imaging based on phosphonate derivatives of Gd-DTPA.
Adzamli IK; Blau M; Pfeffer MA; Davis MA
Invest Radiol; 1991 Nov; 26 Suppl 1():S242-4; discussion S245-7. PubMed ID: 1808139
[No Abstract] [Full Text] [Related]
4. MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging.
Lauffer RB; Parmelee DJ; Ouellet HS; Dolan RP; Sajiki H; Scott DM; Bernard PJ; Buchanan EM; Ong KY; Tyeklár Z; Midelfort KS; McMurry TJ; Walovitch RC
Acad Radiol; 1996 Aug; 3 Suppl 2():S356-8. PubMed ID: 8796603
[No Abstract] [Full Text] [Related]
5. Kinetics and magnetic resonance imaging of Gd-EOB-DTPA in dogs.
Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H
Invest Radiol; 1994 Jun; 29 Suppl 2():S177-8. PubMed ID: 7928221
[No Abstract] [Full Text] [Related]
6. Quantification of liver capillary permeability using a macromolecular contrast agent for magnetic resonance imaging.
Clément O; Vuillemin-Bodaghi V; Cuénod CA; Siauve N; Blustajn J; Frija G
Acad Radiol; 1996 Aug; 3 Suppl 2():S342-3. PubMed ID: 8796598
[No Abstract] [Full Text] [Related]
7. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
[TBL] [Abstract][Full Text] [Related]
8. Paramagnetic dextrans as magnetic resonance blood pool tracers.
Meyer D; Schaefer M; Chambon C; Beaute S
Invest Radiol; 1994 Jun; 29 Suppl 2():S90-2. PubMed ID: 7523330
[No Abstract] [Full Text] [Related]
9. Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media.
Puttagunta NR; Gibby WA; Puttagunta VL
Invest Radiol; 1996 Oct; 31(10):619-24. PubMed ID: 8889650
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.
Schuhmann-Giampieri G; Schmitt-Willich H; Press WR; Negishi C; Weinmann HJ; Speck U
Radiology; 1992 Apr; 183(1):59-64. PubMed ID: 1549695
[TBL] [Abstract][Full Text] [Related]
11. Paradoxic uptake of Gd-EOB-DTPA by hepatocellular carcinoma in mice: quantitative image analysis.
Fujita M; Yamamoto R; Takahashi M; Tsuji T; Yamanaka T; Miyazawa T; Fritz-Zieroth B; Terada N; Kuroda C
J Magn Reson Imaging; 1997; 7(4):768-70. PubMed ID: 9243401
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver.
Pavone P; Patrizio G; Buoni C; Tettamanti E; Passariello R; Musu C; Tirone P; Felder E
Radiology; 1990 Jul; 176(1):61-4. PubMed ID: 2353112
[TBL] [Abstract][Full Text] [Related]
14. Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas.
Brasch RC; Shames DM; Cohen FM; Kuwatsuru R; Neuder M; Mann JS; Vexler V; Mühler A; Rosenau W
Invest Radiol; 1994 Jun; 29 Suppl 2():S8-11. PubMed ID: 7928277
[No Abstract] [Full Text] [Related]
15. The synthesis and evaluation of macrocyclic gadolinium-DTPA-bis(amide) complexes as magnetic resonance imaging contrast agents.
Varadarajan JA; Crofts SP; Carvalho JF; Fellmann JD; Kim SH; Chang CA; Watson AD
Invest Radiol; 1994 Jun; 29 Suppl 2():S18-20. PubMed ID: 7928223
[TBL] [Abstract][Full Text] [Related]
16. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
[TBL] [Abstract][Full Text] [Related]
17. Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.
Harpur ES; Worah D; Hals PA; Holtz E; Furuhama K; Nomura H
Invest Radiol; 1993 Mar; 28 Suppl 1():S28-43. PubMed ID: 8486501
[TBL] [Abstract][Full Text] [Related]
18. Paramagnetic liposomes as magnetic resonance contrast agents.
Unger E; Tilcock C; Ahkong QF; Fritz T
Invest Radiol; 1990 Sep; 25 Suppl 1():S65-6. PubMed ID: 2283260
[No Abstract] [Full Text] [Related]
19. A macromolecular contrast agent for magnetic resonance imaging. Effect of molecular weight on blood pharmacokinetics and enhancement patterns for polylysine-gadopentetate dimeglumine.
Vexler VS; Clément O; Brasch RC
Invest Radiol; 1994 Jun; 29 Suppl 2():S62-4. PubMed ID: 7928273
[No Abstract] [Full Text] [Related]
20. Can gadolinium be safely given in renal failure?
Weissleder R
AJR Am J Roentgenol; 1996 Jul; 167(1):278-9. PubMed ID: 8659405
[No Abstract] [Full Text] [Related]
[Next] [New Search]
